Cargando…

Iduronate-2-sulfatase fused with anti-hTfR antibody, pabinafusp alfa, for MPS-II: A phase 2 trial in Brazil

In Hunter syndrome (mucopolysaccharidosis II [MPS-II]), systemic accumulation of glycosaminoglycans (GAGs) due to a deficiency of iduronate-2-sulfatase (IDS), caused by mutations in the IDS gene, leads to multiple somatic manifestations and in patients with the severe (neuronopathic) phenotype, also...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giugliani, Roberto, Martins, Ana Maria, So, Sairei, Yamamoto, Tatsuyoshi, Yamaoka, Mariko, Ikeda, Toshiaki, Tanizawa, Kazunori, Sonoda, Hiroyuki, Schmidt, Mathias, Sato, Yuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261166/ https://www.ncbi.nlm.nih.gov/pubmed/33781915 http://dx.doi.org/10.1016/j.ymthe.2021.03.019

Ejemplares similares

A Phase 2/3 Trial of Pabinafusp Alfa, IDS Fused with Anti-Human Transferrin Receptor Antibody, Targeting Neurodegeneration in MPS-II
por: Okuyama, Torayuki, et al.
Publicado: (2021)

Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data
por: Giugliani, Roberto, et al.
Publicado: (2021)

Nonclinical safety evaluation of pabinafusp alfa, an anti-human transferrin receptor antibody and iduronate-2-sulfatase fusion protein, for the treatment of neuronopathic mucopolysaccharidosis type II
por: Yamamoto, Ryuji, et al.
Publicado: (2021)

Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial
por: Okuyama, Torayuki, et al.
Publicado: (2019)

Establishment of a hTfR mAb-functionalized HPPS theranostic nanoplatform
por: He, Qi, et al.
Publicado: (2020)

Changes in Glycogen and Glycosaminoglycan Levels in Hepatocytes of Iduronate-2-Sulfatase Knockout Mice before and after Recombinant Iduronate-2-Sulfatase Supplementation
por: Lee, Jee Hyun, et al.
Publicado: (2011)

Bioinformatic Analysis of the Human Recombinant Iduronate 2-Sulfate Sulfatase
por: Morales-Álvarez, Edwin D., et al.
Publicado: (2016)

Insights into Hunter syndrome from the structure of iduronate-2-sulfatase
por: Demydchuk, Mykhaylo, et al.
Publicado: (2017)

Identification of the iduronate-2-sulfatase proteome in wild-type mouse brain
por: Cardona, Carolina, et al.
Publicado: (2019)

Iduronate-2-sulfatase interactome: validation by yeast two-hybrid assay
por: Benincore-Flórez, Eliana, et al.
Publicado: (2022)

Dose-dependent effects of a brain-penetrating iduronate-2-sulfatase on neurobehavioral impairments in mucopolysaccharidosis II mice
por: Morimoto, Hideto, et al.
Publicado: (2022)

Quantification of the enzyme activities of iduronate-2-sulfatase, N-acetylgalactosamine-6-sulfatase and N-acetylgalactosamine-4-sulfatase using liquid chromatography-tandem mass spectrometry
por: Mashima, Ryuichi, et al.
Publicado: (2017)

Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II
por: Chkioua, Latifa, et al.
Publicado: (2011)

Transferrin Receptor-Targeted Iduronate-2-sulfatase Penetrates the Blood-Retinal Barrier and Improves Retinopathy in Mucopolysaccharidosis II Mice
por: Imakiire, Atsushi, et al.
Publicado: (2023)

Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-Sulfatases
por: Saito, Seiji, et al.
Publicado: (2016)

Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II
por: Osaki, Yosuke, et al.
Publicado: (2018)

A cDNA analysis disclosed the discordance of genotype-phenotype correlation in a patient with attenuated MPS II and a 76-base deletion in the gene for iduronate-2-sulfatase
por: Fukuhara, Yasuyuki, et al.
Publicado: (2020)

Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment
por: Mazzoccoli, Gianluigi, et al.
Publicado: (2013)

The Effect of Recombinant Human Iduronate-2-Sulfatase (Idursulfase) on Growth in Young Patients with Mucopolysaccharidosis Type II
por: Żuber, Zbigniew, et al.
Publicado: (2014)

Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan
por: Hattori, Yusuke, et al.
Publicado: (2023)

Iduronate-2-sulfatase transport vehicle rescues behavioral and skeletal phenotypes in a mouse model of Hunter syndrome
por: Arguello, Annie, et al.
Publicado: (2021)

A novel mucopolysaccharidosis type II mouse model with an iduronate-2-sulfatase-P88L mutation
por: Mashima, Ryuichi, et al.
Publicado: (2023)

Divergent developmental trajectories in two siblings with neuropathic mucopolysaccharidosis type II (Hunter syndrome) receiving conventional and novel enzyme replacement therapies: A case report
por: Tomita, Kazuyoshi, et al.
Publicado: (2021)

Treatment of Neuronopathic Mucopolysaccharidoses with Blood–Brain Barrier-Crossing Enzymes: Clinical Application of Receptor-Mediated Transcytosis
por: Sonoda, Hiroyuki, et al.
Publicado: (2022)

A study of the relationship between clinical phenotypes and plasma iduronate-2-sulfatase enzyme activities in Hunter syndrome patients
por: Lee, Ok Jeong, et al.
Publicado: (2012)

Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Iduronate-2-Sulfatase in Rhesus Macaques
por: Hordeaux, Juliette, et al.
Publicado: (2018)

Comparative studies of vertebrate iduronate 2-sulfatase (IDS) genes and proteins: evolution of A mammalian X-linked gene
por: Holmes, Roger S.
Publicado: (2017)

Iduronate-2-Sulfatase-Regulated Dermatan Sulfate Levels Potentiate the Invasion of Breast Cancer Epithelia through Collagen Matrix
por: Singh, Vishal, et al.
Publicado: (2019)

A novel CRISPR/Cas9-based iduronate-2-sulfatase (IDS) knockout human neuronal cell line reveals earliest pathological changes
por: Badenetti, Lorenzo, et al.
Publicado: (2023)

Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of Hunter syndrome
por: Laoharawee, Kanut, et al.
Publicado: (2023)

Multiplexing Iduronate-2-Sulphatase (MPS-II) into a 7-Plex Lysosomal Storage Disorder MS/MS Assay Using Cold-Induced Phase Separation
por: Courtney, Elya, et al.
Publicado: (2023)

Biological functions of iduronic acid in chondroitin/dermatan sulfate
por: Thelin, Martin A, et al.
Publicado: (2013)

The natural history of MPS I: global perspectives from the MPS I Registry
por: Beck, Michael, et al.
Publicado: (2014)

Targeting the Vasculature of Colorectal Carcinoma with a Fused Protein of (RGD)(3)-tTF
por: Huang, Zheng-jie, et al.
Publicado: (2013)

Sulfatase 1 and sulfatase 2 as novel regulators of macrophage antigen presentation and phagocytosis
por: Kim, Hyun-Je, et al.
Publicado: (2021)

Uncovering the Relationship between Sulphation Patterns and Conformation of Iduronic Acid in Heparan Sulphate
por: Hsieh, Po-Hung, et al.
Publicado: (2016)

Diagnosing Mucopolysaccharidosis type IV a by the fluorometric assay of N-Acetylgalactosamine-6-sulfate sulfatase activity
por: Shams, Sedigheh, et al.
Publicado: (2017)

Occurrence of L-iduronic acid and putative D-glucuronyl C5-epimerases in prokaryotes
por: Raedts, John, et al.
Publicado: (2011)

Phylogeny of Algal Sequences Encoding Carbohydrate Sulfotransferases, Formylglycine-Dependent Sulfatases, and Putative Sulfatase Modifying Factors
por: Ho, Chai-Ling
Publicado: (2015)

Radiation hardness of lead glasses TF1 and TF101
por: Kobayashi, M, et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_gcgqbdfthe11h9ll2oqdtdtsju